DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Kas B, Talbot H, Ferrara R. et al.
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non-Small Cell Lung Cancer.
JAMA Oncol 2020;
DOI: 10.1001/jamaoncol.2020.1634.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.